The 20 Best Leukemia Doctors Near Me in Lake Success, NY

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Elite provider by MediFind in the treatment of Leukemia. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as an Elite provider by MediFind in the treatment of Leukemia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome. Dr. Rai is board certified in American Board Of Pediatrics.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Elite provider by MediFind in the treatment of Leukemia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Jacqueline Barrientos is a Hematologist practicing medicine in New Hyde Park, New York. Dr. Barrientos is rated as an Elite provider by MediFind in the treatment of Leukemia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Splenectomy, and Bone Marrow Aspiration.

Douglas Gladstone is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is rated as an Advanced provider by MediFind in the treatment of Leukemia. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Leukemia. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Leukemia. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Leukemia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Goldberg is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Advanced provider by MediFind in the treatment of Leukemia. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

I am a board certified hematologist and medical oncologist. I specialize in caring for patients with hematologic malignancies and specifically myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and aplastic anemia (AA). Dr. Shastri is rated as a Distinguished provider by MediFind in the treatment of Leukemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Adult T-Cell Leukemia, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Ioannis Mantzaris is an Oncologist practicing medicine in Bronx, New York. Dr. Mantzaris is rated as a Distinguished provider by MediFind in the treatment of Leukemia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Adult T-Cell Leukemia, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Gail Roboz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Roboz is rated as an Elite provider by MediFind in the treatment of Leukemia. She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Roboz is currently accepting new patients.

Richard Furman is an Oncologist practicing medicine in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Leukemia. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Furman is currently accepting new patients.

Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia. She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases. She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Lamanna is rated as an Elite provider by MediFind in the treatment of Leukemia. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy. Dr. Lamanna is board certified in Medical Oncology. Dr. Lamanna is currently accepting new patients.

Judith Paula Brody, MD, is a Board-certified hematopathologist, Professor in Anatomic and Clinical Pathology, and past Senior Director of the Division of Hematopathology in the Department of Pathology and Laboratory at NSLIJ, a member of the department since 1986. With expertise in both anatomic and clinical pathology, Dr. Brody specializes in the diagnosis of hematologic disorders from tissue samples like bone marrow. She also oversees one of the laboratories responsible for testing related to hematologic disorders. She completed her MD degree at Northwestern University Feinberg School of Medicine and pursued her residencies at the University of Virginia in Anatomic/Clinical Pathology, and at the New England Deaconess Hospital in Boston, and was a member of the hematopathology department at the University of Pittsburgh Medical Center prior to NSLIJ position. It is important to note that Dr. Brody does not see patients in a clinical capacity and kindly requests not to be contacted for appointments as a clinical hematologist. Dr. Brody is rated as an Experienced provider by MediFind in the treatment of Leukemia. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Leukocytosis, Non-Hodgkin Lymphoma, Adult T-Cell Leukemia, and Acute Myeloid Leukemia (AML).

Hatice Gur is a Pathologist and a Laboratory Medicine provider practicing medicine in Manhasset, New York. Dr. Gur is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML), Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Myelofibrosis. Dr. Gur is board certified in American Board Of Pathology/Anatomic & Clinical and American Board Of Pathology/Hematology.

Rene Ashworth is a Hematologist and an Oncologist practicing medicine in Manhasset, New York. Dr. Ashworth is rated as an Experienced provider by MediFind in the treatment of Leukemia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy. Dr. Ashworth is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Dr. Mark A. Hoffman is the Section Head of Hematology at Long Island Jewish's Division of Hematology/Oncology. Dr. Hoffman is also an Associate Professor of Clinical Medicine at Albert Einstein College of Medicine and was listed as one of the Best Doctors in America, from 2003 through 2007. His interests include breast cancer, gynecologic malignancies, chronic lymphocytic leukemia and malignant lymphomas. Dr. Hoffman is also focused on the development of communication skills in oncology and supportive care. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Leukemia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Endometrial Cancer, Adult Soft Tissue Sarcoma, and Inflammatory Breast Cancer.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Experienced provider by MediFind in the treatment of Leukemia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Stephanie Boisclair, MD, is a bone marrow transplant, cellular therapy, and lymphoma specialist at the R.J. Zuckerberg Cancer Center at Long Island Jewish Medical Center. She is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, where she completed her hematology and oncology fellowship. Dr. Boisclair earned her medical degree from the American University of Antigua and completed her internal medicine residency at Memorial Healthcare System in Florida.She is the recipient of the ASCO Conquer Cancer Young Investigator Award for her work on clinical trials aimed at optimizing outcomes in acute myeloid leukemia. Her research focuses on post-transplant relapse and strategies to improve graft-versus-host disease (GVHD) outcomes. Dr. Boisclair is a member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), European Society for Blood and Marrow Transplantation (EBMT), and the American Society for Transplantation and Cellular Therapy (ASTCT). She collaborates with the Leukemia & Lymphoma Society to promote patient education and health literacy around bone marrow transplant and cellular therapies. Her passion for oncology is rooted in a desire to improve not only survival outcomes but also quality of life for individuals navigating cancer diagnoses and treatments.At Northwell, Dr. Boisclair is known for her compassionate, patient-centered approach. She emphasizes shared decision-making and tailoring treatment plans to reflect each patient's goals, values, and life circumstances. Some of the most meaningful moments come when patients feel seen and supported, she says. I remember one patient who, during a particularly anxious time, simply said, 'I'm glad you're here I know I can ask what I need to.' It reminded me how much trust and presence matter in helping people feel safe and cared for during vulnerable moments.She credits Northwell's interdisciplinary model encompassing physicians, advanced practice providers, nurses, transplant coordinators, social workers and financial counselors with helping patients navigate the complex transplant journey.For Dr. Boisclair, the most rewarding part of her work is seeing patients not just survive but thrive. Every patient I care for teaches me something. Their courage through uncertainty motivates me every day to keep pushing forward in clinical care and research. Dr. Boisclair is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Adult T-Cell Leukemia, and Paroxysmal Cold Hemoglobinuria. Dr. Boisclair is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.